World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
53187
World Ranking
4696
National Ranking
147

Rodolfo Montironi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rodolfo Montironi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,228 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rodolfo Montironi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rodolfo Montironi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 114 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rodolfo Montironi is affiliated with Marche Polytechnic University in Italy and has contributed extensively to the field of medicine, with a primary focus on urologic oncology and related disciplines. Their research spans multiple subfields including pulmonary and respiratory medicine, surgery, oncology, rheumatology, and molecular biology.

Montironi's work covers several main topics: prostate cancer treatment and research, prostate cancer diagnosis and treatment, bladder and urothelial cancer treatments, urinary and genital oncology studies, urologic and reproductive health conditions, renal cell carcinoma treatment, and cancer immunotherapy and biomarkers.

Their recent notable publications include:

  • "Epidemiology of Renal Cell Carcinoma: 2022 Update" (2022), published in European Urology
  • "Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer" (2021), published in Cancers
  • "The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer" (2020), published in Archives of Pathology & Laboratory Medicine
  • "Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications" (2020), published in Cells
  • "Epigenetic modulations and lineage plasticity in advanced prostate cancer" (2020), published in Annals of Oncology

Frequent coauthors collaborating with Montironi include:

  • Alessia Cimadamore
  • Liang Cheng
  • Antonio López-Beltrán
  • Matteo Santoni
  • Marina Scarpelli

Their research is frequently published in venues such as:

  • European Urology
  • Cancers
  • European Urology Oncology
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Translational Andrology and Urology

Montironi's scholarly production includes a substantial number of publications-over 580 across the core field of medicine. Their contributions to urologic oncology have involved both clinical and molecular perspectives, reflecting a multidisciplinary approach.

Their publication topics underline a comprehensive engagement with various urologic cancers and treatment modalities, including diagnostic frameworks and immunotherapy advances. The diversity of their frequent coauthors indicates extensive collaborative networks, contributing to the dissemination and development of knowledge within the specialty of urology and oncology.

Best Publications

  • Bladder cancer: Epidemiology, staging and grading, and diagnosis

    Ziya Kirkali;Theresa Chan;Murugesan Manoharan;Ferran Algaba

  • The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

    John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad

  • 2004 WHO Classification of the Renal Tumors of the Adults

    Antonio Lopez-Beltran;Marina Scarpelli;Rodolfo Montironi;Ziya Kirkali

  • EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

    Kexin Xu;Zhenhua Jeremy Wu;Anna C. Groner;Housheng Hansen He

  • The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

    Brett Delahunt;John C. Cheville;Guido Martignoni;Peter A. Humphrey

  • Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers

    Gladell P. Paner;Walter M. Stadler;Donna E. Hansel;Rodolfo Montironi

  • The controversial relationship between benign prostatic hyperplasia and prostate cancer: The role of inflammation

    Cosimo De Nunzio;Gero Kramer;Michael Marberger;Rodolfo Montironi

  • Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

    Valeria Panebianco;Yoshifumi Narumi;Ersan Altun;Bernard H. Bochner

  • Her-2-neu Expression and Progression Toward Androgen Independence in Human Prostate Cancer

    Sabina Signoretti;Rodolfo Montironi;Judith Manola;Annalisa Altimari

  • Prognostic Factors in Prostate Cancer

    David G. Bostwick;David J. Grignon;M. Elizabeth H. Hammond;Mahul B. Amin

  • Extended and Saturation Prostatic Biopsy in the Diagnosis and Characterisation of Prostate Cancer: A Critical Analysis of the Literature

    Vincenzo Scattoni;Alexandre Zlotta;Rodolfo Montironi;Claude Schulman

  • Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine.

    Liang Cheng;Antonio Lopez-Beltran;Francesco Massari;Gregory T MacLennan

  • Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary Update

    Ofer Yossepowitch;Alberto Briganti;James A. Eastham;Jonathan Epstein

  • The role of focal therapy in the management of localised prostate cancer: a systematic review

    Massimo Valerio;Massimo Valerio;Hashim U Ahmed;Mark Emberton;Nathan L Lawrentschuk

  • PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

    F Massari;M Santoni;C Ciccarese;D Santini

  • International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins

    Puay Hoon Tan;Liang Cheng;John R Srigley;David Griffiths

  • The Contemporary Concept of Significant Versus Insignificant Prostate Cancer

    Guillaume Ploussard;Jonathan I. Epstein;Rodolfo Montironi;Rodolfo Montironi;Peter R. Carroll

  • Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.

    Jonathan I. Epstein;Mahul Amin;Liliane Boccon-Gibod;Lars Egevad

  • The 2004 WHO Classification of Bladder Tumors: A Summary and Commentary:

    Rodolfo Montironi;Antonio Lopez-Beltran

  • Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.

    Theodoros Karantanos;Christopher P. Evans;Bertrand Tombal;Timothy C. Thompson

Frequent Co-Authors

Antonio Lopez-Beltran
Antonio Lopez-Beltran University of Córdoba
Liang Cheng
Liang Cheng Brown University
Gregory T. MacLennan
Gregory T. MacLennan Case Western Reserve University
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Lars Egevad
Lars Egevad Karolinska Institute
Jonathan I. Epstein
Jonathan I. Epstein Johns Hopkins University
Stefano Cascinu
Stefano Cascinu Vita-Salute San Raffaele University
David G. Bostwick
David G. Bostwick Bostwick Laboratories
Puay Hoon Tan
Puay Hoon Tan Duke NUS Graduate Medical School
Mahul B. Amin
Mahul B. Amin University of Tennessee Health Science Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in medicine doesn't always start or end with an MD. A variety of online degrees and career pathways open doors in healthcare, offering flexible, accredited options for different interests and schedules.

Those interested in diet and wellness can consider an online BS in nutrition, which equips graduates for roles in public health, hospitals, or private practice. Healthcare administration is another fast-growing field; a CAHME accredited online MHA program prepares future leaders to manage hospitals and healthcare organizations.

For registered nurses, advancing their education is more accessible than ever. Some pursue the RN to BSN without clinicals pathway, allowing for academic advancement with a flexible online curriculum. Meanwhile, those aiming for the highest levels of clinical practice may opt for shortest DNP programs online to achieve a Doctor of Nursing Practice degree with accelerated options.

Whether supporting patients directly or shaping healthcare systems, these online programs offer valuable, accredited ways to advance your career in medicine-related fields.

Best Scientists Citing Rodolfo Montironi

Trending Scientists

Recently Published Articles